Obalon Announces First Commercial Use of Navigation and Touch Products for Obalon Balloon Administration
To the extent that statements contained in this press release are not descriptions of historical facts regarding
Chief Financial Officer
Office: +1 760 607 5103
Source: Obalon Therapeutics, Inc.